Philadelphia-Israel Chamber of Commerce

  • Home
  • About Us
    • Greater Philadelphia Region & Israel
    • Committees
    • PICC Success Stories
    • Leadership
  • Membership
    • Register now
    • Membership Directory
  • Events
  • BIRD
  • News
    • PICC in the News
    • Blog
  • Contact Us
    • Valuable Contacts
TwitterLinkedinFacebook
Home » News » The Truth and Debunking Myths About Life Science Exits

The Truth and Debunking Myths About Life Science Exits

August 28, 2019 |

Life Science investing is different from Tech investing. There are hurdles faced in testing and clinical trials that don’t have a comparison in the Technology silo. Companies raising money within the Life Sciences silo may need to go through several series of funding and can travel very different journeys to get to an exit. In addition, within Life Science, the strategy of the startup company can differ based on how they choose to navigate the path to exit.

David Baker, Co-Founder,  Vallon Pharmaceuticals

David Baker is a Co-Founder of Vallon Pharmaceuticals and has over 25 years of executive, operational and commercial leadership experience in the biopharmaceutical industry. He has been directly involved with the commercialization of five medications with annual sales in excess of $1 billion each, including Adderall XR® and Vyvanse®, the two most successful ADHD brands based on annual revenue.
In 2017, while serving as the interim CEO of Alcobra Ltd, a NASDAQ listed pharmaceutical company based in Tel Aviv and Philadelphia, David led Alcobra through the successful merger with Arcturus Therapeutics (NASDAQ: ARCT). He also successfully completed the out license of ADAIR, an early stage drug for the treatment of ADHD, which became the basis for forming Vallon Pharmaceuticals which he now leads.

Categories: News

PICC Updates

Archives

  • March 2022
  • February 2022
  • January 2022
  • February 2021
  • September 2020
  • August 2020
  • April 2020
  • March 2020
  • January 2020
  • December 2019
  • September 2019
  • August 2019
  • May 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • September 2018
  • February 2018
  • December 2017
  • September 2017
  • June 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • June 2016
  • April 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • June 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • August 2014
  • July 2014
  • April 2014
  • January 2014

Sponsors

  • The Satell Institute
  • CatholicSeniorHousing
  • Optimized-RCCB_logo_web-96
  • Somatix
  • West logo R 294 only
  • TJU_logo_1012 NEW
  • PEI-All-Blue
  • Permit Capital Advisors
  • Temple University
  • Baker-Tilly-New-Logo
  • BIMBO bakeries
  • bnym_web
  • CenTrak Logo
    CenTrak logo (PRNewsFoto/CenTrak) (PRNewsFoto/CenTrak)
  • drexel crop
  • Fox-Rothschild
  • Healthcare Administrative Partners
  • HenrySchein_2000x374-BW
  • Hershey
  • Intellident Logo
  • JFGP_rgb
  • permit-capital-advisors-llc-logo
  • TempleU Survey
  • Teva_Logo_RGB

Search the site

Contact us

T: 215-703-3135
picc@phillyisraelchamber.com

Connect

Visit us

Location:
21 S 11th Street, 2nd Floor
Philadelphia, PA 19102

© 2022 Philadelphia-Israel Chamber of Commerce | Site maintained by Three Bears Digital